ArticleBiomedicines2025

Evaluation of suPAR as a Key Prognostic Biomarker in Patients with SARS-CoV-2 Pneumonia.

Mónica Piqueras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.